Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis.
Viruses. 2023 Sep 29;15(10):2026. doi: 10.3390/v15102026.
Viruses. 2023.
PMID: 37896803
Free PMC article.
The tolerability of sofosbuvir/velpatasvir for 12 weeks in patients treated in the ASTRAL 1, 2 and 3 studies: A pooled safety analysis.
Jacobson IM, Bourgeois S, Mathurin P, Thuluvath P, Ryder SD, Gerken G, Hernandez C, Vanstraelen K, Scherbakovsky S, Osinusi A, Tedesco D, Foster GR.
Jacobson IM, et al. Among authors: scherbakovsky s.
J Viral Hepat. 2023 May;30(5):448-454. doi: 10.1111/jvh.13814. Epub 2023 Mar 2.
J Viral Hepat. 2023.
PMID: 36740893
Clinical Trial.
Item in Clipboard
Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment.
Sulkowski M, Telep LE, Colombo M, Durand F, Reddy KR, Lawitz E, Bourlière M, Cheinquer N, Scherbakovsky S, Ni L, Force L, Ramroth H, Gaggar A, Chokkalingam AP, Sise ME.
Sulkowski M, et al. Among authors: scherbakovsky s.
Aliment Pharmacol Ther. 2022 May;55(9):1169-1178. doi: 10.1111/apt.16830. Epub 2022 Mar 2.
Aliment Pharmacol Ther. 2022.
PMID: 35235245
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite